Q1 earnings turnaround and shareholder returns in focus

Ryan Specialty Holdings (RYAN) moved from a net loss to a net profit in the first quarter of 2026, with higher revenue, fresh buybacks, and an affirmed quarterly dividend drawing investor attention.

Despite the Q1 turnaround, momentum in Ryan Specialty Holdings' share price has been weak. A 1-day share price return of 7.89% contrasts with a 37.34% year to date share price decline and a 54.37% 1-year total shareholder return decline.

If this earnings move has you reassessing your portfolio, it can help to broaden your watchlist beyond insurance and scan for other ideas using our screener for 19 top founder-led companies

With Ryan Specialty now profitable in Q1, a share price that is down sharply over 1 year, and a discount to analyst price targets and intrinsic estimates, should you see value here, or assume the market is already pricing in future growth?

Most Popular Narrative: 42.6% Undervalued

Ryan Specialty Holdings' most followed narrative pegs fair value at $55.25, well above the last close of $31.71, which puts a spotlight on what assumptions sit behind that gap.

The updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.

Want to know what drives that higher fair value? The core of this narrative is earnings power built on richer margins, slower but still meaningful top line growth, and a future earnings multiple that assumes investors keep paying up for the model. Curious which of those levers does most of the heavy lifting in the calculation?

Result: Fair Value of $55.25 (UNDERVALUED)

However, there are clear watchpoints here, including softer property insurance pricing and execution risk around M&A and new platform investments that could pressure margins.

Another Angle On Valuation

The fair value narrative suggests Ryan Specialty is undervalued at $55.25 versus a $31.71 share price, but the P/E presents a different perspective. At 37.8x earnings, the stock trades well above the US Insurance industry average of 11.4x, peers at 26.3x, and even its own 27.4x fair ratio. This raises a simple question: is the bigger risk now paying too much for growth that may already be reflected in the price?

Next Steps

With sentiment so mixed in the story so far, it helps to move quickly, review the facts yourself, and weigh both sides using the 3 key rewards and 2 important warning signs

Ready to hunt for your next opportunity?

If this earnings story has sharpened your focus, do not stop here. The next stock that fits your goals might already be on a pre filtered list.

• Target reliable income by scanning companies with strong payouts and balance sheets using our 12 dividend fortresses.
• Spot quality at a discount by searching through our hand picked list of screener containing 23 high quality undiscovered gems.
• Dial down portfolio risk by focusing on companies that clear strict balance sheet checks in the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.